Sitago-met 1000 MG/1 TAB , equivalent to  50 mg Sitagliptin Base Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

sitago-met 1000 mg/1 tab , equivalent to 50 mg sitagliptin base

شركة سنا فارما - sana pharma company - metformin hcl 1000 mg/1 tab , sitagliptin phosphate monohydrate equivalent to 50 mg sitagliptin base - 1000 mg/1 tab , equivalent to 50 mg sitagliptin base

Symbicort 100/6 Turbuhaler New Zealand - English - Medsafe (Medicines Safety Authority)

symbicort 100/6 turbuhaler

astrazeneca limited - budesonide 80ug equivalent to 100 µg metered dose;  ;  ;  ; formoterol fumarate 4.5ug equivalent to 6 µg metered dose;   - powder for inhalation - active: budesonide 80ug equivalent to 100 µg metered dose       formoterol fumarate 4.5ug equivalent to 6 µg metered dose   excipient: lactose monohydrate - symbicort turbuhaler is indicated in the treatment of asthma to achieve overall asthma control, including the prevention and relief of symptoms as well as the reduction of the risk of exacerbations. symbicort turbuhaler is suitable for any asthma severity, where the use of inhaled corticosteroids is appropriate.

Symbicort 200/6 Turbuhaler New Zealand - English - Medsafe (Medicines Safety Authority)

symbicort 200/6 turbuhaler

astrazeneca limited - budesonide 160ug equivalent to 200 µg metered dose;  ;  ;  ; formoterol fumarate 4.5ug equivalent to 6 µg metered dose;   - powder for inhalation - active: budesonide 160ug equivalent to 200 µg metered dose       formoterol fumarate 4.5ug equivalent to 6 µg metered dose   excipient: lactose monohydrate - symbicort turbuhaler is indicated in the treatment of asthma to achieve overall asthma control, including the prevention and relief of symptoms as well as the reduction of the risk of exacerbations. symbicort turbuhaler is suitable for any asthma severity, where the use of inhaled corticosteroids is appropriate.

Symbicort 400/12 Turbuhaler New Zealand - English - Medsafe (Medicines Safety Authority)

symbicort 400/12 turbuhaler

astrazeneca limited - budesonide 320ug equivalent to 400 µg metered dose;  ;  ;  ; formoterol fumarate 9ug equivalent to 12 µg metered dose;   - powder for inhalation - active: budesonide 320ug equivalent to 400 µg metered dose       formoterol fumarate 9ug equivalent to 12 µg metered dose   excipient: lactose monohydrate - symbicort turbuhaler is indicated in the treatment of asthma to achieve overall asthma control, including the prevention and relief of symptoms as well as the reduction of the risk of exacerbations. symbicort turbuhaler is suitable for any asthma severity, where the use of inhaled corticosteroids is appropriate.

Alimta New Zealand - English - Medsafe (Medicines Safety Authority)

alimta

eli lilly and company (nz) limited - pemetrexed disodium 151.7mg (as the heptahydrate, equivalent to pemetrexed free acid 100mg) - powder for infusion - 100 mg - active: pemetrexed disodium 151.7mg (as the heptahydrate, equivalent to pemetrexed free acid 100mg) excipient: hydrochloric acid mannitol sodium hydroxide water for injection - · alimta in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. · alimta as monotherapy is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Alimta New Zealand - English - Medsafe (Medicines Safety Authority)

alimta

eli lilly and company (nz) limited - pemetrexed disodium 713mg (as the heptahydrate, equivalent to pemetrexed free acid 500mg) - powder for infusion - 500 mg - active: pemetrexed disodium 713mg (as the heptahydrate, equivalent to pemetrexed free acid 500mg) excipient: mannitol - alimta is indicated for the treatment of patients with malignant pleural mesothelioma in combination with cisplatin.

Calvasc New Zealand - English - Medsafe (Medicines Safety Authority)

calvasc

douglas pharmaceuticals limited - amlodipine mesilate 12.79mg equivalent to amlodipine 10 mg;  ;   - tablet - 10 mg - active: amlodipine mesilate 12.79mg equivalent to amlodipine 10 mg     excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate

Calvasc New Zealand - English - Medsafe (Medicines Safety Authority)

calvasc

douglas pharmaceuticals limited - amlodipine mesilate 6.395mg equivalent to amlodipine 5.0 mg;  ;   - tablet - 5 mg - active: amlodipine mesilate 6.395mg equivalent to amlodipine 5.0 mg     excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate

Arrow - Timolol New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - timolol

teva pharma (new zealand) limited - timolol maleate 3.4 mg/ml equivalent to timolol 2.5 mg/ml - eye drops, solution - 0.25% w/v - active: timolol maleate 3.4 mg/ml equivalent to timolol 2.5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection

Arrow - Timolol New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - timolol

teva pharma (new zealand) limited - timolol maleate 6.8 mg/ml equivalent to timolol 5 mg/ml - eye drops, solution - 0.5% w/v - active: timolol maleate 6.8 mg/ml equivalent to timolol 5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection